Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1482 (LINC01482)

Target
LINC01482
Molecular classification
Other, Long non-coding RNA, lncRNA, Long intergenic non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 1482 (LINC01482) is a long non-coding RNA (lncRNA), meaning it is a RNA transcript longer than 200 nucleotides that does not code for a protein[1][5]. LINC01482 is classified among long intergenic non-coding RNAs, which are known to regulate gene expression through various mechanisms. Published studies indicate that LINC01482 plays a regulatory role in cancer biology, with particular evidence in colorectal cancer. Functionally, LINC01482 acts as a competing endogenous RNA (ceRNA) by sponging microRNAs—specifically, it binds to miR-331, thereby modulating the expression of downstream targets such as human epidermal growth factor receptor 2 (HER2), and promoting activation of key oncogenic pathways, including Akt and ERK1/2 signaling[3]. Experimental studies have shown that knockdown of LINC01482 inhibits cancer cell proliferation and invasion and promotes apoptosis in vitro. There is currently no evidence that LINC01482 is a direct therapeutic target (such as a receptor, enzyme, or transporter), nor is it known to interact with drugs or serve as a biomarker in clinical use; however, it may have potential biomarker or regulatory importance in the context of cancer[1][3][4].

Other names
LINC01482
02

Biological functions

Regulation of cell proliferationRegulation of apoptosisRegulation of signal transductionCompeting endogenous RNA (ceRNA) activityRegulation of gene expression
03

Disease associations

CancerColorectal cancer

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1482 (LINC01482).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1482 (LINC01482).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call